Clinical Trials Directory

Trials / Completed

CompletedNCT05988346

Ghrelin and Diastolic Heart Function

Ghrelin Expression Could Regulate Diastolic Heart Function in Obese Patients With Diabetes

Status
Completed
Phase
Study type
Observational
Enrollment
60 (actual)
Sponsor
University of Campania Luigi Vanvitelli · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

In type 2 diabetes mellitus (T2DM) and obese patients the adipose tissue could over-express cytokines, sirtuin-1 (SIRT1), and microRNAs (miRs) implied in the regulation of left ventricle (LV) diastolic function (LV-DF). Ghrelin could modulate these pathways. Thus, in the current study authors will investigate ghrelin expression in T2DM obese patients after abdominal fat excision, and particularly in those with normalization of LV-DF at 1 year of follow-up.

Conditions

Interventions

TypeNameDescription
PROCEDUREabdominal plastic interventionAccording to international guidelines, authors will remove the superficial abdominal fat from the patients enrolled in the study.

Timeline

Start date
2016-01-01
Primary completion
2022-01-01
Completion
2022-03-01
First posted
2023-08-14
Last updated
2023-08-24

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT05988346. Inclusion in this directory is not an endorsement.